ViroPharma

ViroPharma, a biopharmaceutical company, engages in the development and commercialization of products that address serious diseases

ViroPharma Incorporated, a biopharmaceutical company, engages in the development and commercialization of products that address serious diseases, with a focus on products used by physician specialists or in hospital settings. The company has two marketed products, and three development programs. The company markets and sells Vancocin HCl capsules, the oral capsule formulation of vancomycin hydrochloride, in the U.S. and its territories. Vancocin is a potent antibiotic approved by the U.S. Food and Drug Administration, or the FDA, to treat antibiotic-associated pseudomembranous colitis caused by Clostridium difficile infection (CDI), or C. difficile, and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains.